Loading
Qure.ai
Qure.ai builds deep-learning tools that read radiology scans. Its products include qXR for chest X-rays, qER for head CT, qTrack for lung health management and a lung cancer detection platform launched in June 2026. It sells to hospitals, public health programs and pharma/medical device companies in many countries, mainly through software licensing. It raised a Series D of about $65M in September 2024, and total funding is reported at roughly $123M–$133M depending on the tracker. Its Indian entity reported revenue of about ₹190 Cr for FY2025, and Tracxn lists about 306 employees as of March 2026.
Funding
Every round, secondary, debt facility or acquisition involving Qure.ai that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
$21M